End-of-day quote
Shenzhen S.E.
23:00:00 07/05/2024 BST
|
5-day change
|
1st Jan Change
|
19.25
CNY
|
+2.01%
|
|
+5.60%
|
-31.13%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,159
|
3,780
|
5,774
|
5,614
|
3,803
|
4,806
|
Enterprise Value (EV)
1 |
1,801
|
3,443
|
5,892
|
6,354
|
4,342
|
4,806
|
P/E ratio
|
38.8
x
|
128
x
|
-114
x
|
-44.9
x
|
-16
x
|
-22.5
x
|
Yield
|
0.49%
|
5.25%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
11.8
x
|
21.8
x
|
51.4
x
|
38.4
x
|
7.94
x
|
25.3
x
|
EV / Revenue
|
9.82
x
|
19.8
x
|
52.4
x
|
43.5
x
|
9.06
x
|
25.3
x
|
EV / EBITDA
|
45.6
x
|
178
x
|
-67.2
x
|
-31.7
x
|
-21.7
x
|
-54.4
x
|
EV / FCF
|
98.9
x
|
11.4
x
|
-95.3
x
|
-93.7
x
|
-21.1
x
|
-
|
FCF Yield
|
1.01%
|
8.75%
|
-1.05%
|
-1.07%
|
-4.73%
|
-
|
Price to Book
|
4.24
x
|
7.21
x
|
18.7
x
|
29.9
x
|
35.6
x
|
-
|
Nbr of stocks (in thousands)
|
158,414
|
158,414
|
158,414
|
158,139
|
158,139
|
171,951
|
Reference price
2 |
13.63
|
23.86
|
36.45
|
35.50
|
24.05
|
27.95
|
Announcement Date
|
24/04/19
|
24/04/20
|
28/04/21
|
30/03/22
|
21/04/23
|
23/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
183.3
|
173.5
|
112.4
|
146
|
479.2
|
190.2
|
EBITDA
1 |
39.47
|
19.34
|
-87.62
|
-200.7
|
-200.3
|
-88.38
|
EBIT
1 |
36.82
|
13.19
|
-98.26
|
-215.9
|
-226.5
|
-108.3
|
Operating Margin
|
20.08%
|
7.6%
|
-87.45%
|
-147.87%
|
-47.28%
|
-56.92%
|
Earnings before Tax (EBT)
1 |
66.45
|
37.09
|
-50.54
|
-123.2
|
-241.8
|
-210.6
|
Net income
1 |
55.17
|
29.49
|
-50.38
|
-124.7
|
-236.6
|
-209
|
Net margin
|
30.09%
|
17%
|
-44.84%
|
-85.41%
|
-49.39%
|
-109.85%
|
EPS
2 |
0.3511
|
0.1867
|
-0.3200
|
-0.7900
|
-1.500
|
-1.240
|
Free Cash Flow
1 |
18.22
|
301.3
|
-61.83
|
-67.8
|
-205.5
|
-
|
FCF margin
|
9.94%
|
173.66%
|
-55.03%
|
-46.43%
|
-42.88%
|
-
|
FCF Conversion (EBITDA)
|
46.16%
|
1,557.83%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
33.02%
|
1,021.65%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0662
|
1.253
|
-
|
-
|
-
|
-
|
Announcement Date
|
24/04/19
|
24/04/20
|
28/04/21
|
30/03/22
|
21/04/23
|
23/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
118
|
740
|
538
|
-
|
Net Cash position
1 |
357
|
337
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-1.347
x
|
-3.688
x
|
-2.688
x
|
-
|
Free Cash Flow
1 |
18.2
|
301
|
-61.8
|
-67.8
|
-205
|
-
|
ROE (net income / shareholders' equity)
|
11.2%
|
5.77%
|
-13.7%
|
-50%
|
-142%
|
-
|
ROA (Net income/ Total Assets)
|
4.17%
|
1.45%
|
-7.34%
|
-9.21%
|
-8.3%
|
-
|
Assets
1 |
1,323
|
2,039
|
686.1
|
1,353
|
2,852
|
-
|
Book Value Per Share
2 |
3.220
|
3.310
|
1.950
|
1.190
|
0.6700
|
-
|
Cash Flow per Share
2 |
0.3000
|
0.4700
|
1.210
|
1.330
|
1.300
|
-
|
Capex
1 |
7.21
|
6.66
|
197
|
84.3
|
122
|
246
|
Capex / Sales
|
3.93%
|
3.84%
|
175.25%
|
57.75%
|
25.38%
|
129.31%
|
Announcement Date
|
24/04/19
|
24/04/20
|
28/04/21
|
30/03/22
|
21/04/23
|
23/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -31.13% | 450M | | +5.92% | 104B | | -2.51% | 64.55B | | +51.90% | 41.5B | | +18.29% | 40.01B | | +7.85% | 33.03B | | +12.32% | 20.11B | | +16.99% | 17.52B | | +20.27% | 15.51B | | +10.05% | 15.34B |
Other Commodity Chemicals
|